AB825
Anti-Apolipoprotein J Antibody
Chemicon®, from goat
Sinónimos:
Clusterin, ApoJ
Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
About This Item
UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41
Productos recomendados
biological source
goat
Quality Level
antibody form
affinity purified immunoglobulin
antibody product type
primary antibodies
clone
polyclonal
purified by
affinity chromatography
species reactivity
human
manufacturer/tradename
Chemicon®
technique(s)
ELISA: suitable
immunohistochemistry: suitable (paraffin)
immunoprecipitation (IP): suitable
western blot: suitable
NCBI accession no.
UniProt accession no.
shipped in
wet ice
target post-translational modification
unmodified
Gene Information
human ... CLU(1191)
Specificity
Apolipoprotein J, Human. Negligible cross reactivity to Apo A-I, A-II, B, C-I, C-II, C-III, and E by ELISA. Negligible non-specific cross-reaction with other human serum proteins.
Immunogen
Apolipoprotein J, purified from human plasma.
Application
Anti-Apolipoprotein J Antibody is an antibody against Apolipoprotein J for use in ELISA, IP, WB, IH(P).
Immunoblotting: 1:5,000-1:10,000
Immunohistochemistry on paraffin embedded tissue: 1:50-1:200
Immunoprecipitation
ELISA: 1:5,000-1:10,000
Optimal working dilutions must be determined by end user.
Immunohistochemistry on paraffin embedded tissue: 1:50-1:200
Immunoprecipitation
ELISA: 1:5,000-1:10,000
Optimal working dilutions must be determined by end user.
Research Category
Metabolism
Metabolism
Research Sub Category
Lipid Metabolism & Weight Regulation
Lipid Metabolism & Weight Regulation
Physical form
Affinity purified immunoglobulin. Liquid in 0.125 M Sodium Borate buffer, 0.075 M Sodium Chloride, 0.005 M EDTA, pH 8.0, with 0.01% sodium azide.
Storage and Stability
Maintain at 2-8°C in undiluted aliquots for several weeks. For extended storage mix with an equal volume of glycerol, aliquot contents and freeze at -20°C or below for up to 12 months. Avoid repeated freeze/thaw cycles.
Other Notes
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
¿No encuentra el producto adecuado?
Pruebe nuestro Herramienta de selección de productos.
Optional
Referencia del producto
Descripción
Precios
signalword
Danger
hcodes
Hazard Classifications
Repr. 1B
Storage Class
6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
wgk_germany
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Certificados de análisis (COA)
Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Svetlana Hakobyan et al.
Journal of Alzheimer's disease : JAD, 54(2), 707-716 (2016-08-29)
There is a critical unmet need for reliable markers of disease and disease course in mild cognitive impairment (MCI) and early Alzheimer's disease (AD). The growing appreciation of the importance of inflammation in early AD has focused attention on inflammatory
N Bahia El Idrissi et al.
Clinical and experimental immunology, 184(3), 338-346 (2016-01-11)
Mycobacterium leprae infection gives rise to the immunologically and histopathologically classified spectrum of leprosy. At present, several tools for the stratification of patients are based on acquired immunity markers. However, the role of innate immunity, particularly the complement system, is
Samantha L Hersrud et al.
The FEBS journal, 283(3), 459-471 (2015-11-14)
The neuronal ceroid lipofuscinoses (NCLs) are a group of neurodegenerative genetic diseases that primarily affect children and have no known cure. A unified clinical rating scale for the juvenile form of NCL has been developed, although it has not been
Chera L Maarouf et al.
PloS one, 6(11), e27291-e27291 (2011-11-17)
The amyloid cascade hypothesis provides an economical mechanistic explanation for Alzheimer's disease (AD) dementia and correlated neuropathology. However, some nonagenarian individuals (high pathology controls, HPC) remain cognitively intact while enduring high amyloid plaque loads for decades. If amyloid accumulation is
Chera L Maarouf et al.
PloS one, 9(8), e105784-e105784 (2014-08-29)
Defining the biochemical alterations that occur in the brain during "normal" aging is an important part of understanding the pathophysiology of neurodegenerative diseases and of distinguishing pathological conditions from aging-associated changes. Three groups were selected based on age and on
Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.
Póngase en contacto con el Servicio técnico